The inauguralAPACMed Value-Based Market Access (VBMA) Symposiumwill revolve around the theme “The Evolving Health Technology Assessment Landscape for Medical Devices and Diagnostics”. The MedTech event brings together key stakeholders in the healthcare ecosystem to advocate for innovative, value-based market access – including and not limited to pricing, procurement, value assessment and reimbursement.
The VBMA symposium will leverage technical expertise, real-world operating experience and networks from the extensive community of government affairs and market access industry professionals across over 15 Asia Pacific (APAC) markets from more than 40 companies in the medical device and diagnostics sector.Get your virtual tickets here.
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life science industry. We are dedicated to creating intelligent connections that deliver unique innovations and actionable insights.
The VBMA symposium features IQVIA experts who will provide key insights on policy shaping, impact assessment and implementation of value-based healthcare in the Asia-Pacific region:
Click here to registerfor the VBMA Symposium 2022.